v3.26.3
Business Segment Information (Tables)
 9 Months Ended
Sep. 26, 2026
Segment Reporting [Abstract]  
Schedule of Business Segment Information
Three months ended September 26, 2026
(In millions)Life Sciences SolutionsAnalytical InstrumentsSpecialty DiagnosticsLaboratory Products and Biopharma ServicesTotal
Revenues
Revenues from external customers$2,279 $1,948 $1,090 $6,820 $12,137 
Intersegment revenues440 54 9 43 546 
2,719 2,002 1,098 6,863 12,683 
Elimination of intersegment revenues
(546)
Consolidated revenues
$12,137 
Segment Income
Cost of revenues1,013 953 587 5,180 
Selling, general, and administrative expenses481 323 160 661 
Research and development expenses133 138 46 20 
Other segment items70 51 (35)(65)
Segment income
1,022 538 341 1,067 2,968 
Unallocated amounts
Cost of revenues adjustments
(9)
Selling, general and administrative expenses adjustments
20 
Restructuring and other costs
(199)
Amortization of acquisition-related intangible assets
(519)
Interest income252 
Interest expense(417)
Other income/(expense)
(10)
Consolidated income before income taxes$2,088 
(In millions)Unallocated amountsLife Sciences SolutionsAnalytical InstrumentsSpecialty DiagnosticsLaboratory Products and Biopharma ServicesConsolidated
Segment assets$98,834 $3,597 $3,259 $1,129 $7,414 $114,233 
Purchases of property, plant and equipment35 85 25 21 272 437 
Depreciation of property, plant and equipment— 70 29 18 191 307 
Three months ended September 27, 2025
(In millions)Life Sciences SolutionsAnalytical InstrumentsSpecialty DiagnosticsLaboratory Products and Biopharma ServicesTotal
Revenues
Revenues from external customers$2,194 $1,847 $1,154 $5,927 $11,122 
Intersegment revenues394 46 20 43 503 
2,588 1,893 1,174 5,970 11,626 
Elimination of intersegment revenues
(503)
Consolidated revenues$11,122 
Segment Income
Cost of revenues961 974 682 4,608 
Selling, general, and administrative expenses471 306 175 577 
Research and development expenses134 144 42 14 
Other segment items54 41 (46)(97)
Segment income
968 429 321 868 2,587 
Unallocated amounts
Cost of revenues adjustments
(10)
Selling, general and administrative expenses adjustments
(66)
Restructuring and other costs
(135)
Amortization of acquisition-related intangible assets
(435)
Interest income234 
Interest expense(347)
Other income/(expense)
(2)
Consolidated income before income taxes$1,826 
(In millions)Unallocated amountsLife Sciences SolutionsAnalytical InstrumentsSpecialty DiagnosticsLaboratory Products and Biopharma ServicesConsolidated
Segment assets$88,209 $3,552 $3,189 $1,307 $6,763 $103,020 
Purchases of property, plant and equipment23 32 18 34 297 404 
Depreciation of property, plant and equipment— 62 26 23 115 227 
Nine months ended September 26, 2026
(In millions)Life Sciences SolutionsAnalytical InstrumentsSpecialty DiagnosticsLaboratory Products and Biopharma ServicesTotal
Revenues
Revenues from external customers$6,853 $5,414 $3,402 $19,467 $35,136 
Intersegment revenues1,317 150 43 125 1,635 
8,170 5,564 3,445 19,592 36,771 
Elimination of intersegment revenues
(1,635)
Consolidated revenues
$35,136 
Segment Income
Cost of revenues3,097 2,754 1,942 15,086 
Selling, general, and administrative expenses1,477 951 514 1,935 
Research and development expenses404 416 135 62 
Other segment items175 127 (133)(273)
Segment income
3,017 1,317 987 2,781 8,102 
Unallocated amounts
Cost of revenues adjustments
(51)
Selling, general and administrative expenses adjustments
(59)
Restructuring and other costs
(346)
Amortization of acquisition-related intangible assets
(1,433)
Interest income693 
Interest expense(1,172)
Other income/(expense)
13 
Consolidated income before income taxes$5,746 
(In millions)Unallocated amountsLife Sciences SolutionsAnalytical InstrumentsSpecialty DiagnosticsLaboratory Products and Biopharma ServicesConsolidated
Segment assets$98,834 $3,597 $3,259 $1,129 $7,414 $114,233 
Purchases of property, plant and equipment152 164 77 80 790 1,263 
Depreciation of property, plant and equipment— 209 82 63 593 945 
Nine months ended September 27, 2025
(In millions)Life Sciences SolutionsAnalytical InstrumentsSpecialty DiagnosticsLaboratory Products and Biopharma ServicesTotal
Revenues
Revenues from external customers$6,263 $5,193 $3,402 $17,483 $32,341 
Intersegment revenues1,165 145 54 122 1,487 
7,428 5,339 3,456 17,605 33,828 
Elimination of intersegment revenues
(1,487)
Consolidated revenues
$32,341 
Segment Income
Cost of revenues2,741 2,711 2,001 13,685 
Selling, general, and administrative expenses1,405 937 529 1,760 
Research and development expenses408 426 134 41 
Other segment items152 112 (139)(306)
Segment income
2,722 1,153 932 2,425 7,231 
Unallocated amounts
Cost of revenues adjustments
(31)
Selling, general and administrative expenses adjustments
(99)
Restructuring and other costs
(316)
Amortization of acquisition-related intangible assets
(1,294)
Interest income735 
Interest expense(1,054)
Other income/(expense)
(18)
Consolidated income before income taxes$5,155 
(In millions)Unallocated amountsLife Sciences SolutionsAnalytical InstrumentsSpecialty DiagnosticsLaboratory Products and Biopharma ServicesConsolidated
Segment assets$88,209 $3,552 $3,189 $1,307 $6,763 $103,020 
Purchases of property, plant and equipment85 101 75 92 707 1,060 
Depreciation of property, plant and equipment— 177 76 68 439 758